Business
Why the Genetic Signatures (ASX:GSS) share price is rocketing 25% higher
The Genetic Signatures Ltd (ASX: GSS) share price is rocketing higher on Wednesday after the release of an announcement.
In afternoon trade the specialist molecular diagnostics company’s shares are up almost 25% to $2.12.
Why is the Genetic Signatures share price rocketing higher?
Investors have been fighting to get hold of the company’s shares this afternoon after it announced a major new customer win.
According to the release, the company has signed a deal with Boston Medical Center (BMC) of Boston, Massachusetts, to supply EasyScreen SARS-CoV-2 Detection Kits.
Management notes that the new supply agreement will provide BMC with an expanded testing capability and that it has been signed during a particularly challenging phase…
-
Noosa News23 hours agoMuster Dogs favourite Frank Finger makes final on-screen appearance with kelpie Annie in portrait show
-
General13 hours agoGoldfields man in coma after allegedly smashing head into ambulance windscreen
-
Business21 hours agoShould we be paying more attention to these two rocketing ASX small-cap mining stocks?
-
Noosa News23 hours agoWhy commuters are less likely to see familiar strangers on the bus, train or CityCat and why that makes us feel less safe